Immigration

Tencent Cloud's Robust Infrastructure and Metaverse Innovations Elevate Trident's Flagship Tridentity App to New Level

HONG KONG,March 3,2025-- Tencent Cloud,the cloud business division of global technology company Tencent,today announced its partnership with the Singapore-based Trident Digital Tech Holdings Ltd (&quo

/C O R R E C T I O N -- Chivas Regal/

In the news release,CHARLES LECLERC AND CHIVAS REGAL HIT THE RIGHT NOTE IN NEW GLOBAL PARTNERSHIP,issued 02-Mar-2025 by Chivas Regal over PR Newswire,we are advised by the company that the name of th

Recommend

CStone Announces First Patient Dosed in Global Multicenter Phase I Clinical Trial of CS2009, a PD-1/VEGF/CTLA-4 Trispecific Antibody

Huawei Launches AI-Ready Data Storage for Carriers to Embrace AI

All News

Crisil Coalition Greenwich Announces 2025 Best Bank and Share Leader Award Winners for Corporate Banks

J.P. Morgan and HSBC earn top honors as the world\'s best global corporate bank and corporate FX bank respectively from Crisil Coalition Greenwich

Allianz Partners Announces Dominic Gantner as Managing Director for Greater Southeast Asia

SINGAPORE,Feb. 5,2025-- Allianz Partners,a world leader in insurance and assistance services,has announced the appointment of Dominic Gantner as Managing Director for Greater Southeast Asia (GSEA),ef

ReTo Announces Receipt of Nasdaq Delisting Determination and Plan to Appeal

BEIJING,Feb. 5,2025-- ReTo Eco-Solutions,Inc. (Nasdaq: RETO) ("ReTo" or the "Company"),a manufacturer of equipment for production of eco-friendly materials in China,today announced

MEDCOENERGI IMPROVES MSCI ESG RATING TO "AA"

JAKARTA,Indonesia,Feb. 5,2025-- PT Medco Energi Internasional Tbk (MedcoEnergi) has received an upgrade to its MSCI ESG rating,from "A" to "AA". This recognition positions MedcoEne

Nanoprecise Sci Corp. Renews SOC 2 Type 2 Certification, Reinforcing Commitment to Security Excellence

EDMONTON,AB,Feb. 5,2025--Nanoprecise Sci Corp.,a global leader in Energy-Centered Predictive Maintenance,is pleased to announce the successful renewal of its SOC 2 Type 2 certification,further solidi

Ascletis Announces Positive Results from U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Provides Program Update

ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of patients with obesity,supporting

Jan 26, 2025